MSG's expertise is committed to offering long-term support to our healthcare clients to tackle short-term and long-term challenges and issues to transform the operation risk-free worldwide.
Currently, the healthcare sector witness unprecedented challenges that are changing the focus for the policymakers, payers, providers, and suppliers to rethink. MSG's business consultant and market researcher teams are continuous in-talk with healthcare organizations and companies to evaluate the COVID-19 change and further uniquely positioned to provide updated reports and strategic support to our clients to restructure the business model.
MSG's global healthcare team is dedicated to providing updates related to health IT, digital innovation & transformation, cost optimization techniques, clinical performance improvement, strategy development, market development, market developments, product commercialization, and market estimations & projections. This information under one compiled report is making us the leading provider of quality healthcare research reports.
Today, emerging healthcare technologies are helping companies to respond and get ahead of COVID-19 quickly, but also prepare for the new future reality in the global market.
Mar 2024 | Healthcare & Pharmaceutical
Small Interfering RNA (siRNA) Therapeutics Market by Type (Liposome Based Systemic Therapy, and Nanoparticle Based Systemic Therapy), by Application (Oncology, Cardiovascular Diseases, Neurodegenerative Disorders, Infectious Diseases), and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Weight Loss & Diet Management Market by Product Type Better for you, Meal replacement, Weight loss supplement, Green tea, Low-calorie sweetener), by Sales Channel (Hypermarket/Supermarket, Specialty Stores, Pharmacies, Online Channels, Others), and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Single-Use Bioprocessing Market by Product (Single-use media bags and containers, Single-use assemblies, Single-use bioreactors, Disposable mixers, Others), by Application (Filtration, Storage, Cell culture, Mixing, Purification), by End-User, and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Analgesics Market by Drug Type (Opioid, and Non-opioid, Compound Medication), by Route of Administration (Oral, Parenteral, Transdermal), by Application (Musculoskeletal, Surgical and Trauma, Cancer, Migraine, Obstetrical), by Distribution Channel, and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Cardiac Arrhythmia Monitoring Devices Market by Device (Holter monitor, Event Recorder, Mobile Cardiac Telemetry, Implantable Cardiac Monitor, Electrocardiogram (ECG) Monitor, Others), by Application, by Service Provider, by End User, and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Medical Robotics Market by Product & Services (Instrument & Accessories, Robotic Systems, Services), by Application (Laparoscopy, Orthopedic Surgery, Pharmacy Applications, Physical Rehabilitation, External Beam Radiation Therapy, Neurosurgery, Other Applications), by Solution, by End-User, and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Trifluridine and Tipiracil Tablet Market by Type (15 mg Trifluridine/6.14 mg Tipiracil, and 20 mg Trifluridine/8.19 mg Tipiracil), by Application (Hospital, Pharmacy, Others), by Region (North America, South America, Europe, Asia Pacific, Middle East & Africa) – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Tocilizumab Market by Product Type (Min Purity Less Than 98%, Min Purity 98%-99%, and Min Purity More Than 99%), by Route of Administration (Subcutaneous and Intravenous), by Application, by Dosage Form (Injection, Solution, and Concentrate), by End-Use, and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Trisomy X Market by Type (Periodic Screening, Early Intervention Services, Speech Therapy, Occupational Therapy, Physical or Developmental Therapy, and Psychological Counselling), by Application (Hospitals, Specialty Clinics, and Others), and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Acrocallosal Syndrome Therapeutics Market by Type (Losmapimod, Praluent, and Evolocumab), by Syndrome (ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction, and Unstable Angina), by Route of Administration (Injectable, Oral), and by Region – Global Share and Forecast to 2033